Century Therapeutics, Inc.IPSCNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-104.70M
↓ 36% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-76.76M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-104.70M | +5.1% |
| 2024 | $-110.29M | -8.0% |
| 2023 | $-102.08M | -516.7% |
| 2022 | $-16.55M | +87.6% |
| 2021 | $-133.97M | -162.2% |
| 2020 | $-51.09M | -174.3% |
| 2019 | $-18.63M | - |